Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes
NCT00349128
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
382
Enrollment
INDUSTRY
Sponsor class
Conditions
Dyslipidemia/Glucose Metabolism Disorder
Interventions
DRUG:
fenofibrate and metformin combination (drug)
Sponsor
Solvay Pharmaceuticals